Updates in Treatment Approaches for Ovarian and Endometrial Cancers - Episode 6

Recent Data for PARP Inhibitors in Recurrent Ovarian Cancer

, , , ,

A detailed discussion focused on recent data on PARP inhibitors in the recurrent ovarian cancer setting.

EP. 1: Frontline Maintenance Therapy in Ovarian Cancer
EP. 2: Ovarian Cancer: Deciding Between Treatment Options
EP. 3: Unmet Needs in the Maintenance Setting in Ovarian Cancer
EP. 4: Recent Data on PARP Inhibitors as First-Line Maintenance in Ovarian Cancer
EP. 5: Efficacy of Subsequent Therapies in Advanced Ovarian Cancer
Now Viewing
EP. 6: Recent Data for PARP Inhibitors in Recurrent Ovarian Cancer
EP. 7: Ongoing Trials on Maintenance Therapy in Recurrent Ovarian Cancer
EP. 8: MIRASOL Trial: Mirvetuximab in Platinum-Resistant Ovarian Cancer
EP. 9: Recently Presented Data on Endometrial Cancer
EP. 10: NRG-GY018 and RUBY Trials in Endometrial Cancer
EP. 11: The PHAEDRA Study and Clinical Trial Landscape in Endometrial Cancer
EP. 12: KEYNOTE-775: Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer
EP. 13: Ongoing Trials in Endometrial Cancer
EP. 14: Future Outlook for Treatment of Endometrial Cancer